Article Details

Exponent (NASDAQ:EXPO) Downgraded by Zacks Investment Research

Retrieved on: 2021-08-03 22:18:45

Tags for this article:

Click the tags to see associated articles and topics

Exponent (NASDAQ:EXPO) Downgraded by Zacks Investment Research. View article details on hiswai:

Excerpt

Truist Securities raised their price objective on Exponent from $100.00 to $118.00 and gave the company a "buy" rating in a research report on Monday.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up